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Abstract 
Aim: Obesity and type 2 diabetes present with two debilitating complications, namely, 
hypertension and heart disease. The dried and ground pods of Prosopis glandulosa 
(commonly known as the Honey mesquite tree) which is part of the Fabaceae (or legume) 
family are currently marketed in South Africa as a food supplement with blood glucose-
stabilising and anti-hypertensive properties. We previously determined its hypoglycaemic 
effects, and in the current study we determined the efficacy of P glandulosa as anti-
hypertensive agent and its myocardial protective ability. 
Methods: Male Wistar rats were rendered either pre-diabetic (diet-induced obesity: DIO) or 
hypertensive (high-fat diet: HFD). DIO animals were treated with P glandulosa (100 
mg/kg/day for the last eight weeks of a 16-week period) and compared to age-matched 
controls. Hearts were perfused ex vivo to determine infarct size. Biometric parameters 
were determined at the time of sacrifice. Cardiac-specific insulin receptor  knock-out  
(CIRKO)  mice  were  similarly  treated with P glandulosa and infarct size was determined. 
HFD animals were treated with P glandulosa from the onset of the diet or from weeks 12–16, 
using captopril (50 mg/kg/day) as the positive control. Blood pressure was monitored weekly. 
Results: DIO rats and CIRKO mice: P glandulosa ingestion significantly reduced infarct 
size after ischaemia–reperfusion. Proteins of the PI-3-kinase/PKB/Akt survival pathway 
were affected in a manner supporting cardioprotection. HFD model: P glandulosa treatment 
both prevented and corrected the development of hypertension, which was also reflected in 
alleviation of water retention. 
Conclusion: P glandulosa was cardioprotective and infarct sparing as well as anti-
hypertensive without affecting the body weight or the intra-peritoneal fat depots of the 
animals. Changes in the PI-3-kinase/PKB/Akt pathway may be causal to protection. Results 
indicated water retention, possibly coupled to vasoconstriction in the HFD animals, while 
ingestion of P glandulosa alleviated both. We concluded that treatment of pre-diabetes, type 2 
diabetes or hypertension with P glandulosa poses possible beneficial health effects. 
 
Obesity and type 2 diabetes present with two debilitating complications, namely, 
hypertension and heart disease. The dried and ground pods of Prosopis glandulosa 
(commonly known as the Honey mesquite tree) which is part of the Fabaceae (or legume) 
family are currently marketed as a food supplement with blood glucose stabilising and 
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anti-hypertensive properties in South Africa. In the past, the pods of this tree were used 
as the primary foodstuff for the residents of the south-western regions of the North 
American deserts and these trees are still widely distributed across a large portion of the 
south-western United States.1 The pods are composed of 80% carbohydrate, 13% protein, 
25% fibre and 3% fat, and grinding of the plant is thought to improve its use.2 
 
Obesity is currently classified as a pandemic and is recognised as the leading cause in the 
development of the metabolic syndrome. The metabolic syndrome is described as a cluster 
of pathophysiology outlined by the National Cholesterol Education Program’s Adult 
Treatment Panel III (NCEP: ATP III) and the European Group for the Study of Insulin 
Resistance, to include insulin  resistance  or  glucose  intolerance  (pre-diabetes),  type 2 
diabetes, hypertension and atherogenic dyslipidaemia.3,4 In addition, all of these factors can 
be considered independent risk factors for the development of cardiovascular disease.3 
 
According to the World Health Organisation (WHO), non-communicable diseases such as 
heart disease, stroke, cancer, chronic respiratory diseases and diabetes are currently 
(updated June 2011) the leading causes of mortality in the world.5 This invisible epidemic 
is an under-appreciated cause of poverty and hinders economic development in many 
countries. The burden is growing and the number of people, families and communities 
afflicted is increasing. 
 
The time-line for development of overt type 2 diabetes is described as developing over 
many years. The cardiovascular consequences of this so-called ‘ticking clock’ hypothesis, 
starting from obesity and culminating in type 2 diabetes, is present from the early pre-
diabetic stages.6 
 
In view of the scarcity and cost of modern oral hypoglycaemic agents, plant-based therapies 
for the treatment of diabetes are gaining considerable prominence.7 According to these 
authors more than 400 plant species have been described as having hypoglycaemic 
activity. However, not all of these substances have been researched scientifically to validate 
their efficacy. 
  
We have researched a product from one such plant species, consisting solely of the dried 
and ground pods of the plant P glandulosa, for hypoglycaemic properties.8 In addition, 
potent anti-infective and anti-parasitic compounds have also been isolated from this plant.9 
 
In view of the hypoglycaemic effects of P glandulosa, as well as its ability to partially restore 
the function of pancreatic tissue and increase cardiomyocyte insulin sensitivity,7 we set out 
to determine the cardiovascular effects of treatment, using a well-characterised rat model of 
obesity and pre-diabetes with known cardiovascular insufficiency and endothelial 
dysfunction.10,11 In addition, using a rat model of high-fat feeding known to develop 
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hypertension,12 we determined whether P glandulosa had any effects on the development 
of high blood pressure. 
 
Models 
1. Diet-induced obesity (DIO) 
As described previously,10 Wistar rats (180–200 g) were randomly divided into a control and  
diet  group. The  DIO  group  was fed a diet of normal rat chow supplemented with sucrose 
and condensed milk for a basic period of eight weeks. From weeks eight to 16 the rats were 
treated with P glandulosa (100 mg/ kg/day)  set  in  jelly/gelatine  blocks  and  given  to  
each  one individually according to the weight of the animal.8   This was done to ensure 
absolute compliance and dose control. The dose of P glandulosa was calculated as previously 
described.8 
 
The diet to induce pre-diabetes in the animals was based on hyperphagia.13 Animals were 
anaesthetised with sodium pentobarbital (160 mg/kg, intra-peritoneally) before 
experimentation. At the time of sacrifice, their body weight and the weight of the intra-
peritoneal fat were noted and trunk blood was collected for biochemical analyses. For 
Western blot analyses, the hearts were removed, immediately snap-frozen in liquid nitrogen 
and stored at –80°C. 
 
1. High-fat diet (HFD) 
To induce high blood pressure, the rats were fed a diet containing the following per kg of 
food: cooking fat 400 g, fructose 100 g, casein 100 g, cholesterol 10 g, and rat chow pellets 
390 g. Blood pressure was monitored on a weekly basis over 16 weeks. Treatment with P 
glandulosa (100 mg/kg/day) given in jelly blocks was either started at the onset of the 
diet to study the effect on prevention of the development of hypertension, or after a period of 
12 weeks of the HF diet to study its anti-hypertensive effects. Rats treated with captopril (50 
mg/kg/day) from the onset of the diet were included as a positive control. All animals were 
also placed individually in metabolic cages in order to collect urine samples. 
 
2. CIRKO mice 
A mouse model of animals with a cardiac conditional ablation of the insulin receptor was 
used in conjunction with their C57Bl6 littermates.14 Mice were fed normal chow and 
treated with P glandulosa at a similar dose to that of the rats for a period of eight weeks 
before experimentation. 
 
Methods 
Animals had free access to food and water and were kept on a 12-hour day/night cycle in 
the Central Research Facility of the Faculty of Health Sciences of the University of 
Stellenbosch. The study conformed to the revised South African National Standard for the 
Care and Use of Animals for Scientific Purposes (South African Bureau of Standards, SANS 
10386, 2008) and was registered with the Committee for the use of animals in research of 
the University of Stellenbosch – numbers P05/11/013 and P07/11/020. 
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The P glandulosa plant material was originally obtained from naturally growing plants. The 
material was handled according to a patented and standardised procedure8 and  pre-packed 
in capsules for human consumption, which we emptied and weighed. The voucher specimen 
was reported previously.8 
 
Plasma glucose levels were determined in the fasting state. Blood was obtained via a tail 
prick and glucose levels were determined using a conventional glucometer (Cipla 
MedPro). Plasma was stored at –80°C in a Snijders Scientific Ultracool (Tilburg, the 
Netherlands) and insulin levels were determined using a coat-a-count assay (Diagnostic 
Products). 
 
Intra-peritoneal  glucose  tolerance  curves  (IPGTTs)  were generated in the animals after 
an 18-hour fast. Animals were injected intra-peritoneally with 1 g/kg of a 50% sucrose 
solution and blood glucose levels were monitored over a 120-min period. After removal, the 
hearts were arrested in ice-cold Krebs Henseleit (KH) medium (in mM: NaCl 119, 
NaHCO3  25, KCl 4.75, KH2PO4 1.2, MgSO4 .7H2O 0.6, Na2SO4 0.6, CaCl2 .2H2O 1.25, 
glucose 10) and immediately (within 30 sec) mounted onto the aortic cannula of a perfusion 
rig. The pulmonary vein was connected to a second cannula in order to perform perfusions 
in the working-heart mode with a preload of 15 cm H2O and an afterload of 100 cm H2O, as 
described previously.15 The perfusion medium was continuously gassed with 95% O2 /5% 
CO2. Hearts were fitted with a temperature probe and the temperature was kept constant at 
36.5–37°C. 
 
After a stabilisation period of 30 min, rat hearts were subjected to 35-min regional 
ischaemia by coronary artery ligation, followed by reperfusion for one hour, as described 
previously.15 Infarct size was determined according to a well-established protocol,15 
followed by planimetry, and expressed as a percentage of the area at risk. Planimetry was 
performed blind by a third party. 
 
Mouse hearts were perfused retrogradely, meaning via the aorta without a connection to 
the pulmonary vein. After the 30-min stabilisation period, the hearts were subjected to 20-
min normothermic ischaemic cardiac arrest (NICA) by stopping all perfusion. This was 
followed by one hour of reperfusion, after which the infarct development through the whole 
heart was determined as described above. 
 
To measure blood pressure, rats were placed in restraining holders with a dark nose cone to 
calm them. The restrainers were placed on a heating pad (32 ± 2°C) to warm the rat and 
maintain blood flow to the tail. Animals were placed in the restrainers for at least five 
minutes before monitoring the blood pressure using a computerised tail-cuff blood pressure 
monitor (Kent Scientific Corporation, Connecticut, USA). Prior to commencement of the 
experiment, rats were subjected to the above procedure daily for at least a week to train the 
animals for the procedure and to avoid stress in the rats during experimental determinations. 
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Animals were placed individually in metabolic cages and the volume of urine was determined 
over a period of 24 hours. 
 
 
 
Western blotting 
Frozen tissues were pulverised with a liquid nitrogen pre-cooled mortar and pestle and then 
extracted in lysis buffer containing in mM: Tris-HCl 20 (pH 7.5), EGTA 1, EDTA 1, NaCl 
150, Na2VO3  1, beta-glycerophosphate 1, sodium-pyrophosphate 2.5, PMSF 0.3, Triton X-
100 1% (v/v) plus 10 µg/ml leupeptin and aprotinin, respectively, using a Polytron PT10 
homogeniser, 2 × 4 sec, at setting 4. Lysates were cleared from particulate matter by 
centrifuging for 15 min at 14 000 rpm in a microfuge (Eppendorf Mini-spin plus, Hamburg, 
Germany) and the protein content was determined by the method of Bradford.16  Samples 
were diluted in Laemmli sample buffer, boiled for 5 min and stored at –80°C.  
 
Equal amounts of cytosolic proteins were separated on a SDS poly-acrylamide gel and 
electro-transferred to ImmobilonTM-P PVDF membranes. Transfer and equal loading of 
proteins was determined with Ponceau red reversible stain. The membranes were  blocked  
for  two  hours  in  Tris-buffered  saline  (TBS) containing 0.1% Tween-20 and 5% non-fat 
milk powder and incubated  overnight  in  the  primary  antibodies  (diluted  in TBS–
Tween according to the manufacturer’s instructions). The following  antibodies  from  cell  
signalling  were  used:  insulin receptor beta-subunit, phospho-PI3K P85 (Tyr458), total 
and phospho-PTEN (Ser380/Thr382/383), total and phospho-PKB/Akt (Ser473), Glut 1 
and Glut 4. 
 
Blots were stripped using a 5-min incubation in 2% NaOH after washing in distilled water 
and re-probed with a beta-tubulin antibody to confirm equal loading. Bands were visualised 
using the ECL detection system and quantified by laser-scanning densitometry with suitable 
software (Silk Scientific Inc, USA). For comparison purposes, total pixels of bands were 
expressed as a ratio of the mean of the controls on the same blot. 
 
Statistical analyses 
Data are presented as mean ±SEM were analysed using either a one-way or two-way ANOVA 
followed by a Bonferroni post-hoc test for differences between groups. The blood pressure 
effects were analysed using a repeated-measures two-way ANOVA. Statistical significance 
was set at p <0.05. 
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Results 
After the 16-week diet animals from model 1 (DIO) presented with  significantly  increased  
body-  and  intra-peritoneal  fat weight (Table 1). As summarised in Table 1, these animals 
had significantly elevated blood glucose and insulin levels, leading to an increased 
homeostatic model assessment of insulin resistance index (HOMA-IR), indicative of whole-
body insulin resistance. In neither control nor DIO animals did the treatment with P 
glandulosa have any effect on the body weight or the intra-peritoneal fat weight of the 
animals. After treatment of the DIO animals with P glandulosa, the blood glucose levels 
were no longer significantly elevated compared to the treated controls but the HOMA-IR was 
still significantly higher. However, as shown in Fig. 1, the two-hour blood glucose values after 
intra-peritoneal glucose tolerance analyses were significantly lower in the treated DIO 
animals, underscoring a slight effect on blood glucose handling, as previously reported.8 
 
Infarct size 
After 16 weeks of the obesity-inducing diet, the ex vivo perfused hearts of the DIO animals 
presented with significantly larger infarct sizes, calculated as percentage of the area at risk, 
than the hearts from the control animals (DIO 49.48 ± 3.25 vs control 40.62 ± 2.21%, p < 
0.05, n = 17 per group). The area at risk did not differ between the groups and averaged 54.13 
± 2.21%. 
 
An eight-week treatment regime with P glandulosa in conjunction with the diet significantly 
improved the ability of the hearts to withstand a period of ischaemia, and smaller infarcts 
developed. There was no significant effect in the hearts from control rats (Fig. 2). Two-way 
ANOVA indicated a significant effect of the treatment on infarct size (p < 0.01). 
 
To confirm these results and rule out any effect of insulin levels on the cardioprotective 
role of P glandulosa, we used a mouse model with a conditional ablation of the insulin 
receptor in cardiomyocytes.14 Subjecting these animals and their normal C57Bl6 littermates 
to ex vivo perfusion and NICA, followed by reperfusion, we found that the hearts of both 
control and CIRKO mice were protected by the P glandulosa treatment. This was 
demonstrated by the significantly smaller infarct size observed (Fig. 3). The effect of this 
treatment was highly significant (p < 0.001, n = 9 per group) as indicated by two-way 
ANOVA. 
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Analyses of proteins forming part of the insulin-signalling cascade 
Protection against myocardial damage induced by ischaemia– reperfusion and culminating 
in the formation of an infarct has been ascribed, among others, to the activity of the 
phosphatidyl-inositol-3-kinase (PI-3K) pathway. In view of the previously reported 
improvements in insulin sensitivity of cardiomyocytes, induced by P glandulosa treatment,8 
we systematically analysed the proteins involved in this signalling cascade. 
 
As summarised in Table 2 and shown in  Fig.  4,  hearts from the DIO animals presented 
with a significantly lower phosphorylated:total ratio of the central protein in this cascade, 
protein kinase B or Akt. This ratio was significantly improved by treatment. In addition, the 
expression of the p85 regulatory subunit of the PI-3K enzyme was significantly lower in 
hearts from  the  DIO  animals,  whereas  this  was  not  the  case  after treatment. 
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Treatment also resulted in a lower expression of the phosphatase and tensin homologue 
deleted on chromosome 10 (PTEN) with a higher state of phosphorylation of this enzyme 
(Fig. 5). Phosphorylation of PTEN further inactivates this enzyme, responsible also for the 
dephosphorylation of PKB/ Akt.17,18 
 
Anti-hypertensive effects 
As the DIO diet does not cause high blood pressure, we used a modification of a high-fat 
diet to induce hypertension in the animals.12 As can be seen in Fig. 5, these animals 
developed a significant elevation of their blood pressure within four weeks (HFD 135.88 ± 
2.0 vs control 125.85 ± 1.9 mmHg, p < 0.05, n = 8 per group). 
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We either pre-treated the animals with P glandulosa, starting at the onset of the diet, or we 
allowed the animals to become severely hypertensive (12 weeks) and then started the 
treatment. We included a group of animals treated with the angiotensin converting 
enzyme (ACE) inhibitor captopril from the onset of the diet, as a positive control in this 
study. 
 
As can be seen in Fig. 6A, captopril prevented the development of hypertension in the animals. 
Similarly, P glandulosa treatment prevented the development of high blood pressure in these 
animals when given in conjunction with the high-fat diet. P glandulosa treatment did 
not significantly affect the animals on the control diet (Fig. 6B). In addition, treatment of 
already hypertensive animals (week 12) with P glandulosa normalised their blood pressure 
within two weeks. 
 
Effects on urine production 
Measuring the urine output of the animals by keeping them separately in metabolic 
cages showed that after the 12-week treatment period, the urine output of animals on 
the control diet was 17.37 ± 0.8 ml while those on the high-fat diet had a significantly lower 
urine output of 9.8 ± 0.55 ml (p < 0.001, n = 9 per group). 
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Captopril treatment elevated the urine output to 15 ± 0.9 ml. 
 
Treatment with P glandulosa also elevated urine output to 13.68 ± 0.80 ml (p < 0.01, n =9 
per group) (Fig. 7). 
 
Discussion 
Currently, the world is suffering from a silent epidemic starting with obesity and 
culminating  in  type  2  diabetes.3  Two  of the most debilitating complications of obesity, 
especially centrally located obesity, responsible for the high morbidity and mortality 
associated with such patients are hypertension and heart disease.19,20 In view of the 
need for effective medication to supplement lifestyle changes to control these disease 
states, utilisation of plant-based therapies are currently strongly advocated.7,21 Such 
therapies offer potentially cost-effective management but need scientific validation of their 
effects. 
 
Previous studies from our laboratory  demonstrated  that the dried and ground pods of 
the P glandulosa tree have a potential benefit in the management of both type 1 and type 
2 diabetes.8 In view of the insulin-sensitising effects on isolated cardiomyocytes from rats 
treated with P glandulosa, we aimed to determine whether this product has any 
cardioprotective or anti-hypertensive effects. 
 
In this study, we used three different animal models. The first was a model of pre-
diabetes (DIO), as also indicated by the biometric data presented in Table 1. These 
animals were fed an obesity-inducing diet containing only 16% fat.11,13 DIO animals 
become insulin resistant but not diabetic, as the blood glucose levels never rose above ~ 6.5 
mmol/l. This was however significantly higher than the levels found in the control, chow- 
fed animals. In order to keep the blood glucose levels low, the animals presented with high 
plasma insulin concentrations. 
 
Although P glandulosa treatment did not  significantly alter these parameters, the 
clinically important two-hour blood glucose values after a glucose tolerance test were 
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significantly higher in the DIO animals and were effectively lowered by the treatment (Fig. 
1). This underscores the slight effect on blood glucose handling previously reported.8 
 
Determination of infarct size in ex vivo perfused rat hearts as a measure of myocardial 
damage incurred by ischaemia followed by reperfusion, is taken as the gold standard to 
prove cardioprotection.15 We previously showed that hearts from the DIO rats developed 
larger infarct sizes when subjected to regional ischaemia followed by reperfusion.10 
 
After eight weeks of treatment of DIO rats or CIRKO mice with P glandulosa, it was clearly 
demonstrated that there was an infarct-sparing effect elicited by ingestion of this plant 
material (Figs 2, 3). As the CIRKO mice do not possess a myocardial insulin receptor, the 
protection found in these animals confirmed the results obtained in the rat model and 
underscores that protection does not occur via the insulin-secretory effects of P glandulosa, 
as previously reported.8 
 
One of the best-described and researched mechanisms of protection of the heart against 
ischaemia–reperfusion injury and infarction is activation of the PI-3K, PKB/Akt pathway, 
normally activated by  various  extracellular  substances.22-24  Activation of this pathway 
has several anti-apoptotic effects, leading to limitation of the development of an infarct 
after ischaemia. 
 
In addition, activation of PKB/Akt is a pre-requisite for glucose uptake by the heart.25 
Myocardial glucose is taken up via the two transporters Glut 1 and Glut 4. An improved ability 
to import and utilise glucose is cardioprotective when the heart is subjected to the absence of 
oxygen, as induced by ischaemia. The heart then uses the energy generated by glycolysis to 
protect itself. 
 
Measurement of the expression of both Glut 1 and Glut 4 showed no differences between 
hearts from control and DIO rats. However, the lower ratio of phosphorylated to total 
protein of PKB/Akt found in hearts from the DIO animals may have been detrimental 
during an ischaemic incident. In addition, there was lower expression of the p85 subunit of 
PI-3K documented in these hearts, which may have exacerbated this effect. 
 
Both of these detrimental changes were improved by P glandulosa treatment. The changes 
documented in the phosphatase PTEN will further the positive effects found in both PI-
3K and PKB/Akt as the lower expression and elevated phosphorylation of this enzyme will 
elevate the activity of PKB/ Akt when the latter is stimulated.18 PTEN normally inactivates 
PKB/Akt.17 These changes may play a central role in the protection that P glandulosa 
treatment confers on the heart. 
 
The second rat model was aimed at specifically inducing the development of hypertension. A 
modification of a high-fat diet was used (HFD).12 These animals, in contrast to the DIO 
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animals, developed severe hypertension within a four-week period, as shown in Fig. 6A 
and B. Not only was P glandulosa treatment able to prevent the development of 
hypertension when given in conjunction with the high-fat diet, but it normalised elevated 
blood pressure within two weeks. 
 
The hormonal effects associated with a high-fat diet in rats, namely elevated vasopressin as 
well as activation of the renin– angiotensin system, leading to elevated aldosterone levels 
may both be involved in the development of hypertension in these animals.26-28 
Vasopressin, the anti-diuretic hormone leads to water retention and therefore the 
development of high blood pressure. In addition, it is associated with vasoconstriction.28 
Similar effects can be expected from elevated sympathetic activity, leading to elevated 
aldosterone levels. Measuring the 24-hour urine output of the HFD animals underscored this, 
as the HFD animals had a significantly lower urinary output than the controls. 
 
According to Lee and Blaufox,29 a volume of 16–17 ml urine can be expected from normal 
animals in the weight range of our experimental rats (control 258.49 ± 15.03 vs HFD 327 ± 
12.90 g, p < 0.05, n = 14 per group) while a high-fat diet will result in concentration of this 
volume, indicating water retention. It can also be speculated that, in parallel with the latter 
effect, there will be vasoconstriction, contributing to the observed hypertension. 
  
The  treatment  with  P  glandulosa  was  able  to  alleviate this, thereby adding to  the  
myocardial  protection  observed. To highlight this argument, in the present study both the 
ACE inhibitor and P glandulosa treatment significantly improved urinary flow of the 
animals, in conjunction with lowering the blood pressure. Although this was not measured 
in the current study, we speculate that vasopressin production and aldosterone levels were 
elevated in the HFD rats. P glandulosa treatment may affect the levels of either of these 
hormones, or it may provide a different, hitherto unrecognised mechanism of lowering blood 
pressure in the animals. 
 
Conclusion 
The present study has confirmed our previous results that the dried and ground pods of the 
P glandulosa tree have anti-hyperglycaemic effects. In addition we have conclusively shown 
that this treatment was cardioprotective, as determined by the infarct-sparing effects, and 
anti-hypertensive without affecting the body weight or the intra-peritoneal fat depots of the 
animals. The results indicated that key proteins involved in the cardioprotective PI-3-
kinase/PKB/Akt pathway were affected in a manner that may be causal to this protection. 
 
With regard to the anti-hypertensive effects, the results indicated water retention, possibly 
coupled with vasoconstriction in the HFD animals, while ingestion of P glandulosa alleviated 
both water retention and hypertension. Treatment of pre-diabetes, type 2 diabetes or 
hypertension with P glandulosa therefore poses potentially beneficial health effects besides 
its anti-hyperglycaemic effects. 
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